As shown in Figure 4A, in the two PTEN null/mutant human glioma cell lines (U251HF and SNB19) under serum-free conditions, the suppressive effect of EFEMP1 on AKT phosphorylation was seen 24 hours after the treatment, while total EGFR reduction occurred a day later. Here, EFEMP1 is linked to central nervous system cancer.